Enhertu
fam-trastuzumab deruxtecan-nxki
Listed by Daiichi Sankyo Inc.
- Strength
- 100 mg/5mL
- Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
What it contains
- Trastuzumab Deruxtecan 100 mg/5mL
FDA record
| Dosage form | Injection, Powder, Lyophilized, For Solution |
|---|---|
| Route | Intravenous |
| Approval route | BLA — biologic licence |
| NDC code | 65597-406 |
| FDA application | BLA761139 |
| RxNorm concept | 2267576 |
| Package sizes listed | 1 |
| Marketed since | December 2019 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.